These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 29747872)
1. Early ultrasonographic tumor regression after linear accelerator stereotactic fractionated photon radiotherapy of choroidal melanoma as a predictor for metastatic spread. Mitsch C; Zehetmayer M; Gleiss A; Georg D; Dieckmann K; Pötter R; Sayegh R; Schmidt-Erfurth U; Dunavoelgyi R Radiother Oncol; 2018 Jun; 127(3):385-391. PubMed ID: 29747872 [TBL] [Abstract][Full Text] [Related]
2. Linear accelerator-based stereotactic fractionated photon radiotherapy as an eye-conserving treatment for uveal melanoma. Akbaba S; Foerster R; Nicolay NH; Arians N; Bostel T; Debus J; Hauswald H Radiat Oncol; 2018 Aug; 13(1):140. PubMed ID: 30071857 [TBL] [Abstract][Full Text] [Related]
3. Is it sufficient to repeat LINEAR accelerator stereotactic radiosurgery in choroidal melanoma? Furdova A; Horkovicova K; Justusova P; Sramka M Bratisl Lek Listy; 2016; 117(8):456-62. PubMed ID: 27546698 [TBL] [Abstract][Full Text] [Related]
4. Local tumor control, visual acuity, and survival after hypofractionated stereotactic photon radiotherapy of choroidal melanoma in 212 patients treated between 1997 and 2007. Dunavoelgyi R; Dieckmann K; Gleiss A; Sacu S; Kircher K; Georgopoulos M; Georg D; Zehetmayer M; Poetter R Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):199-205. PubMed ID: 20675066 [TBL] [Abstract][Full Text] [Related]
5. Tumour regression of uveal melanoma after ruthenium-106 brachytherapy or stereotactic radiotherapy with gamma knife or linear accelerator. Georgopoulos M; Zehetmayer M; Ruhswurm I; Toma-Bstaendig S; Ségur-Eltz N; Sacu S; Menapace R Ophthalmologica; 2003; 217(5):315-9. PubMed ID: 12913319 [TBL] [Abstract][Full Text] [Related]
6. Hypofractionated stereotactic photon radiotherapy of posteriorly located choroidal melanoma with five fractions at ten Gy--clinical results after six years of experience. Dunavoelgyi R; Zehetmayer M; Gleiss A; Geitzenauer W; Kircher K; Georg D; Schmidt-Erfurth U; Poetter R; Dieckmann K Radiother Oncol; 2013 Aug; 108(2):342-7. PubMed ID: 24044800 [TBL] [Abstract][Full Text] [Related]
7. [(18)F]Fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) physiologic imaging of choroidal melanoma: before and after ophthalmic plaque radiation therapy. Finger PT; Chin KJ Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):137-42. PubMed ID: 20395070 [TBL] [Abstract][Full Text] [Related]
9. Clinical Predictors of Regression of Choroidal Melanomas after Brachytherapy: A Growth Curve Model. Rashid M; Heikkonen J; Singh AD; Kivelä TT Ophthalmology; 2018 May; 125(5):747-754. PubMed ID: 29499831 [TBL] [Abstract][Full Text] [Related]
10. Stereotactic irradiation on linear accelerator - ultrasound versus MRI in choroidal melanoma volume calculation. Furdova A; Furda R; Sramka M; Chorvath M; Rybar J; Vesely P; Valaskova J; Siska V BMC Ophthalmol; 2022 Aug; 22(1):333. PubMed ID: 35931996 [TBL] [Abstract][Full Text] [Related]
11. Plaque radiotherapy for management of ciliary body and choroidal melanoma with extraocular extension. Gündüz K; Shields CL; Shields JA; Cater J; Brady L Am J Ophthalmol; 2000 Jul; 130(1):97-102. PubMed ID: 11004266 [TBL] [Abstract][Full Text] [Related]
12. Outcomes of treatment with stereotactic radiosurgery or proton beam therapy for choroidal melanoma. Sikuade MJ; Salvi S; Rundle PA; Errington DG; Kacperek A; Rennie IG Eye (Lond); 2015 Sep; 29(9):1194-8. PubMed ID: 26160531 [TBL] [Abstract][Full Text] [Related]
13. Proton beam radiotherapy versus fractionated stereotactic radiotherapy for uveal melanomas: A comparative study. Weber DC; Bogner J; Verwey J; Georg D; Dieckmann K; Escudé L; Caro M; Pötter R; Goitein G; Lomax AJ; Miralbell R Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):373-84. PubMed ID: 16168832 [TBL] [Abstract][Full Text] [Related]
14. Visual Outcome and Millimeter Incremental Risk of Metastasis in 1780 Patients With Small Choroidal Melanoma Managed by Plaque Radiotherapy. Shields CL; Sioufi K; Srinivasan A; Di Nicola M; Masoomian B; Barna LE; Bekerman VP; Say EAT; Mashayekhi A; Emrich J; Komarnicky L; Shields JA JAMA Ophthalmol; 2018 Dec; 136(12):1325-1333. PubMed ID: 30267070 [TBL] [Abstract][Full Text] [Related]
15. [Choroidal melanoma stage T1 - comparison of the planning protocol for stereotactic radiosurgery and proton beam irradiation]. Furdová A; Růžička J; Sramka M; Králik G; Chorváth M; Kusenda P Cesk Slov Oftalmol; 2012 Oct; 68(4):156-61. PubMed ID: 23214488 [TBL] [Abstract][Full Text] [Related]
16. Clinical experience of stereotactic radiosurgery at a linear accelerator for intraocular melanoma. Furdova A; Sramka M; Chorvath M; Kralik G; Furda R; Gregus M Melanoma Res; 2017 Oct; 27(5):463-468. PubMed ID: 28520637 [TBL] [Abstract][Full Text] [Related]
17. Outcomes of medium choroidal melanomas treated with ruthenium brachytherapy guided by three-dimensional pretreatment modeling. Browne AW; Dandapani SV; Jennelle R; Stevanovic M; Lee TC; Murphree AL; Kampp TD; Astrahan MA; Kim JW; Berry JL Brachytherapy; 2015; 14(5):718-25. PubMed ID: 26073224 [TBL] [Abstract][Full Text] [Related]
18. Tumor-height regression rate after brachytherapy between choroidal melanoma gene expression profile classes: effect of controlling for tumor height. Gupta K; McCannel CA; Kamrava M; Lamb J; Almanzor RD; McCannel TA Graefes Arch Clin Exp Ophthalmol; 2016 Jul; 254(7):1371-8. PubMed ID: 26907932 [TBL] [Abstract][Full Text] [Related]
19. Radiogenic side effects after hypofractionated stereotactic photon radiotherapy of choroidal melanoma in 212 patients treated between 1997 and 2007. Dunavoelgyi R; Dieckmann K; Gleiss A; Sacu S; Kircher K; Georgopoulos M; Georg D; Zehetmayer M; Poetter R Int J Radiat Oncol Biol Phys; 2012 May; 83(1):121-8. PubMed ID: 21945109 [TBL] [Abstract][Full Text] [Related]
20. Regression rate of posterior uveal melanomas following iodine-125 plaque radiotherapy. Demirci H; Saponara F; Khan A; Niziol LM; Lee C; Hayman JA; Comer G; Musch DC Middle East Afr J Ophthalmol; 2015; 22(1):103-7. PubMed ID: 25624683 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]